
Decoding the Enigma of Focal-Onset Seizure: A Genetic Approach
Discover the role of genetic testing in diagnosing and managing focal-onset seizures, uncovering underlying causes, and improving treatment strategies for epilepsy patients.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Discover the role of genetic testing in diagnosing and managing focal-onset seizures, uncovering underlying causes, and improving treatment strategies for epilepsy patients.

GISTs arising from the interstitial cells of Cajal can obstruct or perforate the small bowel; KIT and PDGFRA testing plus CD117 and DOG1 staining confirm them.

Fatigue, pain and weakness are worked up step by step with history, examination, blood tests, imaging and EMG, with gene testing for inherited myopathies.

Discover the role of genetic testing in diagnosing and managing generalized tonic-clonic seizures. Learn about the benefits, limitations, and emerging research in this field.

Angiogenesis drives GBM growth, and mutations across 11 signaling pathways, along with VEGFA, CXCL8 and MMP-9, are weighed as combination therapy targets.

Chromosome microarray analysis, whole exome sequencing and findings such as a GNB1 mutation or ERF and CIC deletions are covered as routes to a GDD diagnosis.

GAA enzyme deficiency brings muscle weakness, breathing trouble and heart problems in infantile-onset Pompe disease; sequencing identifies the mutations.

Discover the role of genetic testing in diagnosing and managing hemangiomatosis, a rare disease with abnormal blood vessel growth. Learn about its types, causes, and treatment…